Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Joby Aviation
JOBY
|
$453M |
| 2 |
Datadog
DDOG
|
$423M |
| 3 |
Cloudflare
NET
|
$378M |
| 4 |
Mercado Libre
MELI
|
$311M |
| 5 |
Amazon
AMZN
|
$290M |
Top Sells
| 1 |
Tesla
TSLA
|
$750M |
| 2 |
Booking.com
BKNG
|
$484M |
| 3 |
Netflix
NFLX
|
$450M |
| 4 |
Spotify
SPOT
|
$372M |
| 5 |
Carvana
CVNA
|
$364M |
Sector Composition
| 1 | Consumer Discretionary | 27.35% |
| 2 | Technology | 24.66% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ascendis Pharma
ASND
$12.5B
| $8.08M | 0.01% |
90,502
-1,191
| -1% | -$106K |
|
227
Burford Capital
BUR
$2.91B
| $7.84M | 0.01% |
643,107
-1,151,455
| -64% | -$14M |
|
228
FTI Consulting
FCN
$5.43B
| $7.67M | 0.01% |
40,323
-11,000
| -21% | -$2.09M |
|
229
Health Catalyst
HCAT
$238M
| $7.38M | 0.01% |
590,454
-11,309
| -2% | -$141K |
|
230
Fortive
FTV
$16.1B
| $7.31M | 0.01% |
97,814
| – | – |
|
|
NBTX
231
Nanobiotix
NBTX
$406M
| $7.25M | 0.01% |
1,400,000
| – | – |
|
|
TRHC
232
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $6.86M | 0.01% |
831,278
| – | – |
|
233
dLocal
DLO
$3.82B
| $6.76M | 0.01% |
553,846
-204,048
| -27% | -$2.49M |
|
234
Nike
NKE
$110B
| $6.53M | 0.01% |
59,159
+59,069
| +65,632% | +$6.52M |
|
235
Globus Medical
GMED
$8.2B
| $6.53M | 0.01% |
109,660
-436
| -0.4% | -$26K |
|
236
Tandem Diabetes Care
TNDM
$841M
| $6.45M | 0.01% |
262,756
-187
| -0.1% | -$4.59K |
|
|
HUYA
237
Huya Inc
HUYA
$798M
| $6.32M | 0.01% |
1,765,711
| – | – |
|
238
EOG Resources
EOG
$64.4B
| $6.13M | 0.01% |
+53,557
| New | +$6.13M |
|
239
GitLab
GTLB
$7.46B
| $5.73M | ﹤0.01% |
112,179
-1,225
| -1% | -$62.6K |
|
240
Compañía de Cervecerías Unidas
CCU
$2.3B
| $5.44M | ﹤0.01% |
335,114
-22,786
| -6% | -$370K |
|
|
AKLI
241
DELISTED
Akili, Inc. Common Stock
AKLI
| $5.18M | ﹤0.01% |
4,665,795
| – | – |
|
242
Relay Therapeutics
RLAY
$707M
| $5.17M | ﹤0.01% |
411,308
-4,355
| -1% | -$54.7K |
|
243
LivePerson
LPSN
$87.3M
| $4.66M | ﹤0.01% |
1,030,519
+4,928
| +0.5% | +$22.3K |
|
|
SAGE
244
DELISTED
Sage Therapeutics
SAGE
| $4.41M | ﹤0.01% |
93,719
-1,326
| -1% | -$62.3K |
|
245
NextEra Energy, Inc.
NEE
$146B
| $4.15M | ﹤0.01% |
55,982
+4,466
| +9% | +$331K |
|
246
Freshpet
FRPT
$2.69B
| $4.12M | ﹤0.01% |
62,599
+54,413
| +665% | +$3.58M |
|
|
NCNA
247
NuCana
NCNA
$5.67M
| $2.89M | ﹤0.01% |
732
| – | – |
|
|
CLLS
248
Cellectis
CLLS
$261M
| $2.8M | ﹤0.01% |
1,418,996
-220,900
| -13% | -$435K |
|
249
Inspire Medical Systems
INSP
$2.56B
| $2.54M | ﹤0.01% |
7,829
+7,644
| +4,132% | +$2.48M |
|
250
MongoDB
MDB
$26.4B
| $2.45M | ﹤0.01% |
5,952
-287
| -5% | -$118K |
|